AQR Capital Management
IMNM icon

AQR Capital Management’s Immunome IMNM Stock Holding History

AQR Capital Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$250K Sell
11,780
-6,948
-37% -$149K ﹤0.01% 3712
2026
Q1 		$410K Buy
+18,728
New +$417K ﹤0.01% 3235
2025
Q1 		– Sell
-10,276
Closed -$109K – 3170
2024
Q4 		$109K Sell
10,276
-11,703
-53% -$141K ﹤0.01% 2757
2024
Q3 		$321K Buy
21,979
+5,915
+37% +$84K ﹤0.01% 2365
2024
Q2 		$194K Buy
16,064
+4,129
+35% +$64.6K ﹤0.01% 2427
2024
Q1 		$295K Buy
+11,935
New +$242K ﹤0.01% 2134

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

AQR Capital Management's IMNM Position: Q2 2026 in Review

AQR Capital Management reduced its Immunome (IMNM) stake by 37% in Q2 2026, selling an estimated $149K and leaving 11,780 shares worth $250K. The position accounts for ﹤0.01% of the portfolio, ranked #3712.

AQR Capital Management first reported a position in IMNM in Q1 2024 and has held it in 6 quarters since. The position peaked at $410K in Q1 2026. 203 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • AQR Capital Management held 11,780 shares of Immunome worth $250K as of Q2 2026.
  • AQR Capital Management sold 6,948 Immunome shares in Q2 2026, an estimated $149K.
  • Immunome made up ﹤0.01% of AQR Capital Management's portfolio in Q2 2026, its #3712 holding.
  • AQR Capital Management first reported a position in Immunome in Q1 2024 and has held it in 6 quarters since.
  • AQR Capital Management's Immunome position peaked at $410K in Q1 2026.
  • 203 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.